-
Journal of Neurosurgery Aug 1996
Topics: Diagnosis, Differential; Dura Mater; Humans; Meningioma; Neoplasm Invasiveness; Skull Neoplasms
PubMed: 8755774
DOI: 10.3171/jns.1996.85.2.0362a -
Neurocirugia (Asturias, Spain) Dec 2001Parosteal osteosarcoma of the skull is a distinct surface bone tumor, with a better prognosis than conventional osteosarcoma. The most common location is on the surface... (Review)
Review
Parosteal osteosarcoma of the skull is a distinct surface bone tumor, with a better prognosis than conventional osteosarcoma. The most common location is on the surface of the distal femur which accounts for 46-66% of the cases. The presentation in the skull is uncommon and there are few cases reported in the literature. We describe the case of a man who developed a parosteal osteosarcoma arising from the occipital bone with extension to the parietal bone. The patient was operated and had a complete tumor resection.
Topics: Cerebral Angiography; Chemotherapy, Adjuvant; Combined Modality Therapy; Craniotomy; Diagnosis, Differential; Disease Progression; Fatal Outcome; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Occipital Bone; Osteosarcoma; Osteosarcoma, Juxtacortical; Parietal Bone; Radiotherapy, Adjuvant; Skull Neoplasms; Tomography, X-Ray Computed
PubMed: 11787402
DOI: 10.1016/s1130-1473(01)70671-9 -
The Israel Medical Association Journal... Sep 2019
Topics: Aged; Bone Neoplasms; Female; Humans; Immunoglobulin M; Multiple Myeloma; Skull Neoplasms
PubMed: 31542914
DOI: No ID Found -
Neurosurgical Review Jan 2018Hemangiomas are benign, slow-growing tumors composed of sinusoidal blood vessels. Skeletal hemangiomas are uncommon and are mostly vertebral, followed by cranial in... (Review)
Review
Hemangiomas are benign, slow-growing tumors composed of sinusoidal blood vessels. Skeletal hemangiomas are uncommon and are mostly vertebral, followed by cranial in location. Cranial hemangiomas are very rarely encountered in children. Authors report a 12-year girl who presented with a painless enlarging mass over the parietal scalp for 3 months. Imaging revealed a left parietal intraosseous lytic mass with a sunburst appearance. Enbloc removal and cranioplasty was performed, and histopathology was suggestive of hemangioma. We reviewed the literature on pediatric cranial intraosseous hemangiomas (PCIH) (age ≤18 years) by searching online database. Including ours, a total of 24 cases were analyzed. Mean age was 10.2 years (range 4 months-17 years). Eight were in the first decade and 16 were in the second decade. Male:female ratio was 12:12 (1:1). A painless palpable mass was the commonest presenting feature. Parietal and frontal bones were most commonly involved. Intracranial extension was noted in cases. Mean size of the lesion was 5 cm (range 1-12 cm). Twenty-two underwent primary surgical removal while two had additional pre-operative embolization. Surgical procedures were craniectomy alone (n-3), craniectomy + cranioplasty (n-6), tumor excision + remodeling (n-3), and tumor debulking (n-2). Histopathology was cavernous type in majority of cases. Mean follow-up duration was 11.8 months (range 2-38 months). There were no recurrences. One patient died due to systemic infection. Ours is the first review exclusively on PCIH. Although rare, they need to be considered in the differential diagnosis of lytic skull lesions in children. Enbloc removal with cranioplasty is the preferred treatment in vault hemangiomas, while embolization followed by debulking would suffice in large cranial base lesions.
Topics: Child; Diagnosis, Differential; Hemangioma; Humans; Neoplasm Recurrence, Local; Skull; Skull Neoplasms
PubMed: 27558363
DOI: 10.1007/s10143-016-0779-7 -
The Journal of Craniofacial Surgery Nov 2008Intraosseous hemangiomas are classified as benign tumors of vascular nature. Some authors describe them as hamartomas. They originate and expand inside bone structures.... (Review)
Review
Intraosseous hemangiomas are classified as benign tumors of vascular nature. Some authors describe them as hamartomas. They originate and expand inside bone structures. They are usually congenital, rarely of posttraumatic origin. In the Maxillo-Facial Surgery departments of the Universities of Rome "La Sapienza" and "Tor Vergata," from 1990 to 2004, 11 cases of intraosseous hemangioma have been diagnosed. In 6 cases, the neoplasm localized in the zygomatic region; in 3 cases, at the mandible level; in 1 patient, in the maxillary site; and in 1 patient, in the frontal bone. Literature review and the case of a male patient affected by left orbitozygomatic hemangioma are described.
Topics: Adult; Bone Transplantation; Female; Follow-Up Studies; Hemangioma; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Orbital Neoplasms; Plastic Surgery Procedures; Skull Neoplasms; Surgical Flaps; Temporal Muscle; Tomography, X-Ray Computed; Young Adult; Zygoma
PubMed: 19098533
DOI: 10.1097/SCS.0b013e318188a030 -
Postgraduate Medical Journal Jun 2020
Topics: Antineoplastic Agents; Fatal Outcome; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiotherapy; Skull Neoplasms; Tomography, X-Ray Computed
PubMed: 31792113
DOI: 10.1136/postgradmedj-2019-137006 -
Otolaryngology--head and Neck Surgery :... Jan 1986Chondrosarcoma of the skull base is an uncommon neoplasm that comprises 0.15% of all intracranial tumors and 6% of skull base lesions. Compression of vital neurologic...
Chondrosarcoma of the skull base is an uncommon neoplasm that comprises 0.15% of all intracranial tumors and 6% of skull base lesions. Compression of vital neurologic structures by tumor expansion as well as the histologic characteristics contribute to the malignant potential of these neoplasms. Tumor recurrence has been associated with incomplete resection in this traditionally surgically inaccessible region. This review of five cases of chondrosarcoma of the skull base examines the surgical approaches to resection in a chronologic fashion to emphasize that total gross resection of these lesions has become possible through the evolution of lateral skull base techniques. The difficulty in pathologic diagnosis and the efficacy of postoperative radiotherapy in enhancing survival are also addressed.
Topics: Adult; Aged; Chondrosarcoma; Female; Humans; Male; Middle Aged; Petrous Bone; Skull Neoplasms
PubMed: 3081852
DOI: 10.1177/019459988609400104 -
Journal of Neurosurgery May 2010
Topics: Cranial Fossa, Posterior; Humans; Meningioma; Neoplasm Invasiveness; Neurosurgical Procedures; Patient Positioning; Skull Neoplasms
PubMed: 19877804
DOI: 10.3171/2009.7.JNS091000 -
Medicine Jul 2016Epithelioid hemangioedothelioma (EHE) is a rare vascular tumor characterized by neoplastic proliferation of epithelioid or histiocytoid epithelial cells. EHE of bone...
INTRODUCTION
Epithelioid hemangioedothelioma (EHE) is a rare vascular tumor characterized by neoplastic proliferation of epithelioid or histiocytoid epithelial cells. EHE of bone constitutes <1% of primary malignant bone tumor. EHE in the skull is an extremely rare case. Here, we report a case of multiple neoplasm of the skull in a 15-month-old boy who presented with gradual facial swelling for 2 months. On computed tomography (CT) scan, multiple irregular osteolytic lesions were seen on the right maxillary, sphenoid, left zygoma, and roof of the left orbit. Excisional surgery of the lesion was planned. Histopathological and immunohistochemical examination of excised specimen suggest it to be epithelioid hemangioedothelioma. Follow-up for 6 months showed no recurrence.
CONCLUSION
Epithelioid hemangioedothelioma is a locally aggressive tumor with metastatic potential. CT imaging could help in assessment of lesion, but final diagnosis is possible only with histopathology. Complete surgical resection at the early stage of the disease is the most effective treatment with better prognosis.
Topics: Hemangioendothelioma, Epithelioid; Humans; Infant; Male; Neoplasms, Multiple Primary; Skull Neoplasms
PubMed: 27472681
DOI: 10.1097/MD.0000000000004081 -
Neurosurgical Review Feb 2020Intraosseous cavernous malformations (ICMs) of the skull are relatively rare, benign, and slow-growing tumors. Knowledge of these lesions is poor. The goals of this...
Intraosseous cavernous malformations (ICMs) of the skull are relatively rare, benign, and slow-growing tumors. Knowledge of these lesions is poor. The goals of this study were to describe the clinical manifestations, radiological features, and long-term surgical outcomes of this disease. We performed a retrospective analysis of a series of 16 cranial ICM patients who underwent surgical treatment in our hospital between 2003 and 2016. The incidence of cranial ICM was 1.15% among the entire series of intracranial and intraspinal CMs. Our cohort included 6 male and 10 female patients; their mean age at operation was 38.7 years (range, 1.9 to 63 years). Slowly growing swelling was the commonest clinical manifestation of this disease. Complete lesion resection was achieved in all but one patient, and cranioplasty was performed using titanium mesh in 11 cases. Postoperative complication was found in one patient who developed diplopia, and this symptom resolved spontaneously before discharge. The mean follow-up period after operation was 76.2 months (range, 19 to 119 months). Only the patient with petroclival ICM had some occasional headaches (mRS = 1); others were all in stable neurological status (mRS = 0). No lesion recurrence was found during the follow-up period. Although cranial ICM is rare, it should always be considered as a differential diagnosis in the case of firm, gradually enlarging skull lesions. Surgical resection should be the treatment of choice for the symptomatic patients and their long-term outcomes were excellent after gross total removal.
Topics: Adolescent; Adult; Child; Child, Preschool; Diagnosis, Differential; Female; Headache; Hemangioma, Cavernous, Central Nervous System; Humans; Incidence; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Retrospective Studies; Skull Neoplasms; Treatment Outcome; Young Adult
PubMed: 30327895
DOI: 10.1007/s10143-018-1042-1